Strain Name:

B10.129S2(B6)-Cd4tm1Litt/J

Stock Number:

002447

Availability:

Repository-Cryopreserved

Description

The genotypes of the animals provided may not reflect those discussed in the strain description or the mating scheme utilized by The Jackson Laboratory prior to cryopreservation. Please inquire for possible genotypes for this specific strain.

Strain Information

Type Congenic; Mutant Strain; Targeted Mutation;
Additional information on Genetically Engineered and Mutant Mice.
Visit our online Nomenclature tutorial.
Additional information on Congenic nomenclature.
Specieslaboratory mouse
Background Strain C57BL/10
Donor Strain 129S2 via D3 ES cell line
GenerationN6F11p
 
Donating Investigator Dan Littman,   New York University Medical Center

Appearance
black
Related Genotype: a/a

Description
Mice homozygous for the Cd4tm1 targeted mutation have a significant block in CD4+ T-cell development; 90% of their circulating T-cells are CD8+. Homozygous mutant mice also show a Class II restricted deficit in helper T-cell activity and other T-cell responses.

Control Information

  Control
   000665 C57BL/10J
 
  Considerations for Choosing Controls

Related Strains

Strains carrying other alleles of Cd4
002663   B6.129S2-Cd4tm1Mak/J
002269   B6.129S6-Cd4tm1Knw/J
002664   B6;129S-Cd4tm1Mak Cd8atm1Mak/J
002268   B6;129S6-Cd4tm1Knw/J
006483   CBy.129S2(B6)-Cd4tm1Mak/J
003090   NOD.129S6(B6)-Cd4tm1Knw/DvsJ
005328   NOD/ShiLt-Tg(Cd4-DsRed)4Lt/J
View Strains carrying other alleles of Cd4     (7 strains)

Additional Web Information

Congenic Nomenclature

Phenotype

Phenotype Information

View Mammalian Phenotype Terms

Mammalian Phenotype Terms
      assigned by genotype

The following phenotype information may relate to a genetic background differing from this JAX® Mice strain.

Cd4tm1Litt/Cd4tm1Litt

        involves: 129S2/SvPas
  • immune system phenotype
  • abnormal CD4-positive T cell physiology (MGI Ref ID J:50435)
    • antibody production by B cells in response to the T cell dependent antigen TNP-KLH is 10-fold less than in controls
  • absent CD4-positive T cells (MGI Ref ID J:50435)
    • CD4 T cells are absent from both the thymus and the periphery
  • decreased T cell proliferation (MGI Ref ID J:50435)
    • CD4 T cells have decreased levels of proliferation in mixed lymphocyte cultures with cells expressing class II alloantigen
  • increased CD8-positive T cell number (MGI Ref ID J:50435)
    • 90% of peripheral alphabeta T cell are CD8-positive
    • 93% of thymocytes are CD8-positive
  • hematopoietic system phenotype
  • absent CD4-positive T cells (MGI Ref ID J:50435)
    • CD4 T cells are absent from both the thymus and the periphery
  • decreased T cell proliferation (MGI Ref ID J:50435)
    • CD4 T cells have decreased levels of proliferation in mixed lymphocyte cultures with cells expressing class II alloantigen
  • increased CD8-positive T cell number (MGI Ref ID J:50435)
    • 90% of peripheral alphabeta T cell are CD8-positive
    • 93% of thymocytes are CD8-positive
View Research Applications

Research Applications
This mouse can be used to support research in many areas including:

Cd4tm1Litt related

Immunology and Inflammation Research
CD Antigens, Antigen Receptors, and Histocompatibility Markers

Genes & Alleles

Gene & Allele Information

 
Allele Symbol Cd4tm1Litt
Allele Name targeted mutation, Dan R Littman
Allele Type Targeted (knock-out)
Common Name(s) CD4-; Cd4tm1Drl;
Mutation Made By Dan Littman,   New York University Medical Center
Strain of Origin129S2/SvPas
ES Cell Line NameD3
ES Cell Line Strain129S2/SvPas
Gene Symbol and Name Cd4, CD4 antigen
Chromosome 6
Gene Common Name(s) CD4mut; L3T4; Ly-4; W3/25; lymphocyte antigen 4; p55;
Molecular Note A neomycin resistance gene was inserted into exon 5. No cell surface expression of the encoded protein was detected in T cells and thymocytes derived from homozygous mice (data not shown). [MGI Ref ID J:50435]

Genotyping

Genotyping Information

Genotyping Protocols

Generic Cd4, STD PCR, vers. 1

Helpful Links

Optimizing PCR Protocols

References

References

Selected Reference(s)

Killeen N; Sawada S; Littman DR. 1993. Regulated expression of human CD4 rescues helper T cell development in mice lacking expression of endogenous CD4. EMBO J 12(4):1547-53. [PubMed: 8467804]  [MGI Ref ID J:50435]

Additional References

Cd4tm1Litt related

Adleman LM; Wofsy D. 1996. Blind T-cell homeostasis in CD4-deficient mice. J Acquir Immune Defic Syndr Hum Retrovirol 11(4):334-40. [PubMed: 8601219]  [MGI Ref ID J:34682]

Ali M; Weinreich M; Balcaitis S; Cooper CJ; Fink PJ. 2003. Differential regulation of peripheral CD4+ T cell tolerance induced by deletion and TCR revision. J Immunol 171(11):6290-6. [PubMed: 14634147]  [MGI Ref ID J:132828]

Blair PJ; Bultman SJ; Haas JC; Rouse BT; Wilkinson JE; Godfrey VL. 1994. CD4+CD8- T cells are the effector cells in disease pathogenesis in the scurfy (sf) mouse. J Immunol 153(8):3764-74. [PubMed: 7930593]  [MGI Ref ID J:20865]

Boyer O; Marodon G; Cohen JL; Lejeune L; Irinopoulou T; Liblau R; Bruneval P; Klatzmann D. 2002. Human CD4 expression at the late single-positive stage of thymic development supports T cell maturation and peripheral export in CD4-deficient mice. J Immunol 169(8):4347-53. [PubMed: 12370367]  [MGI Ref ID J:120171]

Bry L; Brenner MB. 2004. Critical role of T cell-dependent serum antibody, but not the gut-associated lymphoid tissue, for surviving acute mucosal infection with Citrobacter rodentium, an attaching and effacing pathogen. J Immunol 172(1):433-41. [PubMed: 14688352]  [MGI Ref ID J:87077]

Bry L; Brigl M; Brenner MB. 2006. CD4+-T-cell effector functions and costimulatory requirements essential for surviving mucosal infection with Citrobacter rodentium. Infect Immun 74(1):673-81. [PubMed: 16369024]  [MGI Ref ID J:104251]

Burrer R; Buchmeier MJ; Wolfe T; Ting JP; Feuer R; Iglesias A; von Herrath MG. 2007. Exacerbated pathology of viral encephalitis in mice with central nervous system-specific autoantibodies. Am J Pathol 170(2):557-66. [PubMed: 17255324]  [MGI Ref ID J:117906]

Cao L; Deleo JA. 2008. CNS-infiltrating CD4(+) T lymphocytes contribute to murine spinal nerve transection-induced neuropathic pain. Eur J Immunol 38(2):448-458. [PubMed: 18196515]  [MGI Ref ID J:131283]

Chan S; Correia-Neves M; Dierich A; Benoist C; Mathis D. 1998. Visualization of CD4/CD8 T cell commitment. J Exp Med 188(12):2321-33. [PubMed: 9858518]  [MGI Ref ID J:113263]

Chesnutt MS; Finck BK; Killeen N; Connolly MK; Goodman H; Wofsy D. 1998. Enhanced lymphoproliferation and diminished autoimmunity in CD4-deficient MRL/lpr mice. Clin Immunol Immunopathol 87(1):23-32. [PubMed: 9576007]  [MGI Ref ID J:47163]

Elhage R; Gourdy P; Brouchet L; Jawien J; Fouque MJ; Fievet C; Huc X; Barreira Y; Couloumiers JC; Arnal JF; Bayard F. 2004. Deleting TCR alpha beta+ or CD4+ T lymphocytes leads to opposite effects on site-specific atherosclerosis in female apolipoprotein E-deficient mice. Am J Pathol 165(6):2013-8. [PubMed: 15579444]  [MGI Ref ID J:94976]

Evel-Kabler K; Song XT; Aldrich M; Huang XF; Chen SY. 2006. SOCS1 restricts dendritic cells' ability to break self tolerance and induce antitumor immunity by regulating IL-12 production and signaling. J Clin Invest 116(1):90-100. [PubMed: 16357940]  [MGI Ref ID J:105256]

Fujimoto M; Tsutsui H; Xinshou O; Tokumoto M; Watanabe D; Shima Y; Yoshimoto T; Hirakata H; Kawase I; Nakanishi K; Kishimoto T; Naka T. 2004. Inadequate induction of suppressor of cytokine signaling-1 causes systemic autoimmune diseases. Int Immunol 16(2):303-14. [PubMed: 14734616]  [MGI Ref ID J:88972]

Harris DP; Koch S; Mullen LM; Swain SL. 2001. B cell immunodeficiency fails to develop in cd4-deficient mice infected with bm5: murine aids as a multistep disease. J Immunol 166(10):6041-9. [PubMed: 11342621]  [MGI Ref ID J:69348]

He X; Park K; Wang H; He X; Zhang Y; Hua X; Li Y; Kappes DJ. 2008. CD4-CD8 lineage commitment is regulated by a silencer element at the ThPOK transcription-factor locus. Immunity 28(3):346-58. [PubMed: 18342007]  [MGI Ref ID J:132996]

Ishikawa H; Hisaeda H; Taniguchi M; Nakayama T; Sakai T; Maekawa Y; Nakano Y; Zhang M; Zhang T; Nishitani M; Takashima M; Himeno K. 2000. CD4(+) v(alpha)14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major. Int Immunol 12(9):1267-74. [PubMed: 10967021]  [MGI Ref ID J:110502]

Kawakami K; Kinjo Y; Yara S; Koguchi Y; Uezu K; Nakayama T; Taniguchi M; Saito A. 2001. Activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans. Infect Immun 69(1):213-20. [PubMed: 11119508]  [MGI Ref ID J:67758]

Killeen N; Littman DR. 1993. Helper T-cell development in the absence of CD4-p56lck association. Nature 364(6439):729-32. [PubMed: 8355789]  [MGI Ref ID J:113011]

Laub R; Brecht R; Dorsch M; Valey U; Wenk K; Emmrich F. 2002. Anti-Human CD4 Induces Peripheral Tolerance in a Human CD4(+), Murine CD4(-), HLA-DR(+) Advanced Transgenic Mouse Model. J Immunol 169(6):2947-55. [PubMed: 12218108]  [MGI Ref ID J:78960]

Laub R; Dorsch M; Meyer D; Ermann J; Hedrich HJ; Emmrich F. 2000. A multiple transgenic mouse model with a partially humanized activation pathway for helper T cell responses. J Immunol Methods 246(1-2):37-50. [PubMed: 11121545]  [MGI Ref ID J:102719]

Leitenberg D; Boutin Y; Constant S; Bottomly K. 1998. CD4 regulation of TCR signaling and T cell differentiation following stimulation with peptides of different affinities for the TCR. J Immunol 161(3):1194-203. [PubMed: 9686579]  [MGI Ref ID J:118762]

Locksley RM; Reiner SL; Hatam F; Littman DR; Killeen N. 1993. Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice. Science 261(5127):1448-51. [PubMed: 8367726]  [MGI Ref ID J:113010]

Maldonado MA; MacDonald GC; Kakkanaiah VN; Fecho K; Dransfield M; Sekiguchi D; Cohen PL; Eisenberg RA. 1999. Differential control of autoantibodies and lymphoproliferation by Fas ligand expression on CD4+ and CD8+ T cells in vivo. J Immunol 163(6):3138-42. [PubMed: 10477580]  [MGI Ref ID J:119603]

Marschner S; Hunig T; Cambier JC; Finkel TH. 2002. Ligation of human CD4 interferes with antigen-induced activation of primary T cells. Immunol Lett 82(1-2):131-9. [PubMed: 12008044]  [MGI Ref ID J:113525]

Matechak EO; Killeen N; Hedrick SM; Fowlkes BJ. 1996. MHC class II-specific T cells can develop in the CD8 lineage when CD4 is absent. Immunity 4(4):337-47. [PubMed: 8612128]  [MGI Ref ID J:88852]

Miyazaki T; Dierich A; Benoist C; Mathis D. 1996. LAG-3 is not responsible for selecting T helper cells in CD4-deficient mice. Int Immunol 8(5):725-9. [PubMed: 8671660]  [MGI Ref ID J:33272]

Muller KP; Kyewski BA. 1995. Intrathymic T cell receptor (TcR) targeting in mice lacking CD4 or major histocompatibility complex (MHC) class II: rescue of CD4 T cell lineage without co-engagement of TcR/CD4 by MHC class II. Eur J Immunol 25(4):896-902. [PubMed: 7737291]  [MGI Ref ID J:24487]

Rajan TV; Nelson FK; Killeen N; Shultz LD; Yates JA; Bailis JM; Littman DR; Greiner DL. 1994. CD4+ T-lymphocytes are not required for murine resistance to the human filarial parasite, Brugia malayi. Exp Parasitol 78(4):352-60. [PubMed: 7911434]  [MGI Ref ID J:110741]

Santori FR; Arsov I; Lilic M; Vukmanovic S. 2002. Editing autoreactive TCR enables efficient positive selection. J Immunol 169(4):1729-34. [PubMed: 12165493]  [MGI Ref ID J:120705]

Saunders BM; Frank AA; Orme IM; Cooper AM. 2002. CD4 is required for the development of a protective granulomatous response to pulmonary tuberculosis. Cell Immunol 216(1-2):65-72. [PubMed: 12381351]  [MGI Ref ID J:115550]

Serpe CJ; Coers S; Sanders VM; Jones KJ. 2003. CD4+ T, but not CD8+ or B, lymphocytes mediate facial motoneuron survival after facial nerve transection. Brain Behav Immun 17(5):393-402. [PubMed: 12946661]  [MGI Ref ID J:105952]

Strong J; Wang Q; Killeen N. 2001. Impaired survival of T helper cells in the absence of CD4. Proc Natl Acad Sci U S A 98(5):2566-71. [PubMed: 11226279]  [MGI Ref ID J:67872]

Sun JC; Bevan MJ. 2004. Cutting edge: long-lived CD8 memory and protective immunity in the absence of CD40 expression on CD8 T cells. J Immunol 172(6):3385-9. [PubMed: 15004136]  [MGI Ref ID J:88609]

Tatari-Calderone Z; Brogdon JL; Tinsley KW; Ramezani A; Leitenberg D. 2005. CD4-dependent signaling is required for a late checkpoint during Th2 development associated with resistance to activation-induced cell death. J Immunol 175(9):5629-36. [PubMed: 16237052]  [MGI Ref ID J:119360]

Zhou X; Robertson AK; Rudling M; Parini P; Hansson GK. 2005. Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis. Circ Res 96(4):427-34. [PubMed: 15662027]  [MGI Ref ID J:106869]

von Herrath MG; Yokoyama M; Dockter J; Oldstone MB; Whitton JL. 1996. CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge. J Virol 70(2):1072-9. [PubMed: 8551565]  [MGI Ref ID J:30536]

Health & husbandry

Health & Colony Maintenance Information

Colony Maintenance

Diet Information LabDiet® 5K52/5K67

Purchasing information

Pricing, Supply Level & Notes, Controls, General Terms & Conditions

Pricing

Pricing for USA, Canada and Mexico shipping destinations View International pricing
Price (US dollars $)
Cryorecovery Fee $1900.00
Animals Provided

At least two mice that carry the mutation (if it is a mutant strain) will be provided. Their genotypes may not reflect those discussed in the strain description. Please inquire for possible genotypes and see additional details below.

Additional Supply Details

Pricing for International shipping destinations View USA Canada and Mexico pricing
Price (US dollars $)
Cryorecovery Fee $2470.00
Animals Provided

At least two mice that carry the mutation (if it is a mutant strain) will be provided. Their genotypes may not reflect those discussed in the strain description. Please inquire for possible genotypes and see additional details below.

Additional Supply Details

Supply Details

Standard SupplyCryopreserved. Ready for recovery. Please refer to pricing and supply notes for further information.
Supply Notes
  • Cryorecovery - Standard.
    At least two mice that carry the mutation (if it is a mutant strain) will be provided. The total number of animals provided, their gender and genotype will vary. Please inquire if larger numbers of animals with specific genotypes and genders are needed. IMPORTANT NOTE: The genotypes of the animals provided may not reflect the mating scheme utilized by The Jackson Laboratory prior to cryopreservation, or that discussed in the strain description. Please inquire for possible genotypes for this specific strain. Animals typically ship within 13 to 16 weeks from your order. If a second cryorecovery is needed in order to provide the minimum number of animals, animals will typically ship within 25 weeks.

    Cryorecovery to establish a Dedicated Supply for greater quantities of mice.
    One to two pairs will be recovered to establish a Dedicated Supply of mice. Price by quotation. For more information on Dedicated Supply, please contact JAX® Services, Tel: 1-800-422-6423 or 1-207-288-5845.

  • This strain is included in the Induced Mutant Resource Colony collection.
  • Genomic DNA is available for this strain from the Mouse DNA Resource.

Control Information

  Control
   000665 C57BL/10J
 
  Considerations for Choosing Controls
  USA, Canada and Mexico - Control Pricing Information for Genetically Engineered Mutant Strains.
  International - Control Pricing Information for Genetically Engineered Mutant Strains.

General Terms and Conditions


See Terms of Use


The Jackson Laboratory's Genotype Promise

The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project.
Ordering and Purchasing Information

      Purchasing Information
      JAX® Mice Orders
      Surgical Services

Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form

Terms of Use

Terms of Use


General Terms and Conditions


Contact information

General inquiries

Contracts Administration

phone:207-288-6470
fax:207-288-6655

JAX® Mice & Services Conditions of Use

“Each recipient institution, including its employees and other researchers under its control (RECIPIENT), of mice or services using mice from The Jackson Laboratory (TJL) agrees that such mice, descendants of those mice derived by inbreeding or crossbreeding, including unmodified derivatives of those mice or their descendants (“MICE”) shall not be: (i) used for any purpose other than the internal research of the RECIPIENT, (ii) sold or otherwise provided to any third party for any use, or (iii) provided to any agent or other third party to provide breeding or other services with respect to MICE. Acceptance of MICE from TJL shall be deemed agreement by RECIPIENT to these conditions, and departure from these conditions requires The Jackson Laboratory’s prior written authorization.”

No Warranty

MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. THE LABORATORY EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.

In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of MICE, products or services, The Jackson Laboratory will, at its option, provide credit or replacement for the MICE or product received or the services provided.

No Liability

In no event shall The Jackson Laboratory, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, products or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of The Jackson Laboratory, its agents or employees. In purchasing or receiving MICE, products or services from The Jackson Laboratory, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges The Jackson Laboratory from all such causes of action or damages, and further agrees to defend and indemnify The Jackson Laboratory from any costs or damages arising out of any third party claims.

MICE and biological materials are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.

The foregoing represents the General Terms and Conditions applicable to The Jackson Laboratory’s MICE, products and services. In addition, special terms and conditions of sale of certain MICE, products and services may be set forth separately in The Jackson Laboratory web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, products and services by The Jackson Laboratory, and by its licensees and distributors.

Acceptance of delivery of MICE, products or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on The Jackson Laboratory, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, products services by The Jackson Laboratory.


(3.4)